150 related articles for article (PubMed ID: 33857583)
1. ERα-agonist and ERβ-antagonist bifunctional next-generation bisphenols with no halogens: BPAP, BPB, and BPZ.
Liu X; Matsuyama Y; Shimohigashi M; Shimohigashi Y
Toxicol Lett; 2021 Jul; 345():24-33. PubMed ID: 33857583
[TBL] [Abstract][Full Text] [Related]
2. Bisphenol AF: Halogen bonding effect is a major driving force for the dual ERα-agonist and ERβ-antagonist activities.
Liu X; Suyama K; Shiki J; Torikai K; Nose T; Shimohigashi M; Shimohigashi Y
Bioorg Med Chem; 2020 Feb; 28(3):115274. PubMed ID: 31879182
[TBL] [Abstract][Full Text] [Related]
3. Bisphenol-C is the strongest bifunctional ERα-agonist and ERβ-antagonist due to magnified halogen bonding.
Liu X; Suyama K; Nose T; Shimohigashi M; Shimohigashi Y
PLoS One; 2021; 16(2):e0246583. PubMed ID: 33561155
[TBL] [Abstract][Full Text] [Related]
4. Bisphenol AF as an Inducer of Estrogen Receptor β (ERβ): Evidence for Anti-estrogenic Effects at Higher Concentrations in Human Breast Cancer Cells.
Okazaki H; Takeda S; Kakizoe K; Taniguchi A; Tokuyasu M; Himeno T; Ishii H; Kohro-Ikeda E; Haraguchi K; Watanabe K; Aramaki H
Biol Pharm Bull; 2017; 40(11):1909-1916. PubMed ID: 29093337
[TBL] [Abstract][Full Text] [Related]
5. Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors.
Liu X; Sakai H; Nishigori M; Suyama K; Nawaji T; Ikeda S; Nishigouchi M; Okada H; Matsushima A; Nose T; Shimohigashi M; Shimohigashi Y
Toxicol Appl Pharmacol; 2019 Aug; 377():114610. PubMed ID: 31195007
[TBL] [Abstract][Full Text] [Related]
6. Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta.
Matsushima A; Liu X; Okada H; Shimohigashi M; Shimohigashi Y
Environ Health Perspect; 2010 Sep; 118(9):1267-72. PubMed ID: 20427257
[TBL] [Abstract][Full Text] [Related]
7. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro.
Li Y; Burns KA; Arao Y; Luh CJ; Korach KS
Environ Health Perspect; 2012 Jul; 120(7):1029-35. PubMed ID: 22494775
[TBL] [Abstract][Full Text] [Related]
8. Editor's Highlight: Transcriptome Profiling Reveals Bisphenol A Alternatives Activate Estrogen Receptor Alpha in Human Breast Cancer Cells.
Mesnage R; Phedonos A; Arno M; Balu S; Corton JC; Antoniou MN
Toxicol Sci; 2017 Aug; 158(2):431-443. PubMed ID: 28591870
[TBL] [Abstract][Full Text] [Related]
9. In silico binding of 4,4'-bisphenols predicts in vitro estrogenic and antiandrogenic activity.
Conroy-Ben O; Garcia I; Teske SS
Environ Toxicol; 2018 May; 33(5):569-578. PubMed ID: 29392883
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
[TBL] [Abstract][Full Text] [Related]
11. Differential
Li Y; Perera L; Coons LA; Burns KA; Tyler Ramsey J; Pelch KE; Houtman R; van Beuningen R; Teng CT; Korach KS
Environ Health Perspect; 2018 Jan; 126(1):017012. PubMed ID: 29389661
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
Maruyama K; Nakamura M; Tomoshige S; Sugita K; Makishima M; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2013 Jul; 23(14):4031-6. PubMed ID: 23768907
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
14. Estrogenicity of halogenated bisphenol A: in vitro and in silico investigations.
Zhang J; Li T; Wang T; Yuan C; Zhong S; Guan T; Li Z; Wang Y; Yu H; Luo Q; Wang Y; Zhang T
Arch Toxicol; 2018 Mar; 92(3):1215-1223. PubMed ID: 29152682
[TBL] [Abstract][Full Text] [Related]
15. Bisphenol AF as an activator of human estrogen receptor β1 (ERβ1) in breast cancer cell lines.
Okazaki H; Hirao-Suzuki M; Takeda S; Takemoto Y; Mizunoe R; Haraguchi K; Watanabe K; Takiguchi M; Aramaki H
J Toxicol Sci; 2018; 43(5):321-327. PubMed ID: 29743443
[TBL] [Abstract][Full Text] [Related]
16. Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner.
Katchy A; Pinto C; Jonsson P; Nguyen-Vu T; Pandelova M; Riu A; Schramm KW; Samarov D; Gustafsson JÅ; Bondesson M; Williams C
Toxicol Sci; 2014 Mar; 138(1):21-35. PubMed ID: 24284790
[TBL] [Abstract][Full Text] [Related]
17. Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta.
Hiroi H; Tsutsumi O; Momoeda M; Takai Y; Osuga Y; Taketani Y
Endocr J; 1999 Dec; 46(6):773-8. PubMed ID: 10724352
[TBL] [Abstract][Full Text] [Related]
18. Bisphenol AF stimulates transcription and secretion of C-X-C chemokine ligand 12 to promote proliferation of cultured T47D breast cancer cells.
Li M; Han X; Gao W; Chen F; Shao B
Toxicology; 2015 Dec; 338():30-6. PubMed ID: 26435001
[TBL] [Abstract][Full Text] [Related]
19. Direct interactions in the recognition between the environmental estrogen bisphenol AF and human serum albumin.
Yang L; Lv J; Wang X; Zhang J; Li Q; Zhang T; Zhang Z; Zhang L
J Mol Recognit; 2015 Aug; 28(8):459-66. PubMed ID: 25694370
[TBL] [Abstract][Full Text] [Related]
20. Endocrine-Disrupting Chemicals (EDCs): In Vitro Mechanism of Estrogenic Activation and Differential Effects on ER Target Genes.
Li Y; Luh CJ; Burns KA; Arao Y; Jiang Z; Teng CT; Tice RR; Korach KS
Environ Health Perspect; 2013 Apr; 121(4):459-66. PubMed ID: 23384675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
